US EditionPublished • loading... • Updated
Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders
Two women awarded $40 million after a jury found Johnson & Johnson concealed decades of asbestos risk in talc baby powder linked to ovarian cancer.
- A jury awarded $40 million to two cancer patients who claimed Johnson & Johnson's talcum powder caused their ovarian cancer.
- Internal J&J documents from the 1970s showed the company knew its baby powder contained asbestos and put public health at risk, according to testimony.
- Medical experts testified that frequent genital talc use increases ovarian cancer risk by at least 50%, potentially doubling with long-term use.
Insights by Ground AI
26 Articles
26 Articles
Associated Press News+5 Reposted by 5 other sources
Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders
A Los Angeles jury has awarded $40 million to two women who claim Johnson & Johnson's talcum powder caused their ovarian cancer. The company plans to appeal the verdict.
·United States
Read Full Article
Johnson & Johnson Ordered To Pay $40 Million In Latest Baby Powder Cancer Trial
A California jury awarded $40 million to two women who said Johnson & Johnson’s talc-based baby powder caused their ovarian cancer. J&J plans to appeal the verdict amid thousands of ongoing lawsuits.
·New Delhi, India
Read Full Article
Coverage Details
Total News Sources26
Leaning Left7Leaning Right2Center6Last UpdatedBias Distribution47% Left
Bias Distribution
- 47% of the sources lean Left
47% Left
L 47%
C 40%
13%
Factuality
To view factuality data please Upgrade to Premium
